Nephrogenic diabetes insipidus
GtoPdb Disease Summaries
This section gives an overview of the disease, and where available shows the following:
- Synonyms: Shows known synonyms for the disease.
- Description: Gives a basic description/definition of the disease.
- Database Link: External links to the same disease at the Disease Ontology, OMIM or Orphanet sites.
- Immunopharmacology comments: General comments about the target's role in immunopharmacology, provided by GtoImmuPdb curators.
- Associated with: Counts are displayed for the total targets the disease is associated with in GtoPdb. The counts of targets and ligands of immunological relevance associated to the disease are also shown.
More information can be found in the help pages.
✖| Disease ID: | 672 | |
| Name: | Nephrogenic diabetes insipidus | |
| Associated with: | 1 target | |
| Database Links |
|
Disease Ontology:
DOID:12387 OMIM: 304800 Orphanet: ORPHA223 |
Targets
GtoPdb Disease Summaries - Targets
Click on the target name to link to its detailed view page
Where available, information is display on the role of the target in the disease; drugs which target the disease and their therapeutic use and side-effects.
If there is mutation data curated in GtoPdb this is indicated, with a link back to the appropriate section on the target detailed view page
Immuno ligand interactions - If available, a table of immuno-relevant ligands is shown. These ligands have been curated as having an association to the disease and possess interaction data with the target in GtoPdb. The approval status of the ligand is shown, along with curator comments and an indication of whether the target is considered the primary target of the ligand.
More information can be found in the help pages.
✖| V2 receptor | |
| Comments: | 183 mutations of the AVPR2 gene have been found in X-linked nephrogenic diabetes insipidus patients. 89 missense, 18 nonsense, 45 frameshift deletion or insertion, 7 in-frame deletion or insertion, 4 splice-site, 19 large deletion, 1 complex mutation. |
| References: | 1-31 |
Ligands
GtoPdb Disease Summaries - Ligands
Click ligand name to view ligand summary page
- Approved: If the ligand is an approved drug this is indicated, along with approval bodies.
- Immuno: Immuno icon indicates the ligand is immuno-relevant
Click the arrow in the final column to expand comments
- Immuno Disease Comments: Curatorial comments specifically added as part of GtoImmuPdb. They give more information on the association between the ligand and disease in the context of immunopharmacology.
- Clinical Use: General clinical comments relating to the ligand and may not necessarily be specific to the disease in question. With hyperlink to more details on the ligand summary pages.
- Bioactivty Comments: Curatorial comments specifically about the compounds biological activity - with hyperlink to more details on the ligand summary pages.
More information can be found in the help pages.
✖No ligand related data available for Nephrogenic diabetes insipidus
References
1. Ala Y, Morin D, Mouillac B, Sabatier N, Vargas R, Cotte N, Déchaux M, Antignac C, Arthus MF, Lonergan M et al.. (1998) Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol, 9 (10): 1861-72. [PMID:9773787]
2. Albertazzi E, Zanchetta D, Barbier P, Faranda S, Frattini A, Vezzoni P, Procaccio M, Bettinelli A, Guzzi F, Parenti M et al.. (2000) Nephrogenic diabetes insipidus: functional analysis of new AVPR2 mutations identified in Italian families. J Am Soc Nephrol, 11 (6): 1033-43. [PMID:10820167]
3. Bichet DG. (2006) Nephrogenic diabetes insipidus. Adv Chronic Kidney Dis, 13 (2): 96-104. [PMID:16580609]
4. Bichet DG, Turner M, Morin D. (1998) Vasopressin receptor mutations causing nephrogenic diabetes insipidus. Proc Assoc Am Physicians, 110 (5): 387-94. [PMID:9756088]
5. Birnbaumer M. (1999) Vasopressin receptor mutations and nephrogenic diabetes insipidus. Arch Med Res, 30 (6): 465-74. [PMID:10714359]
6. Chan Seem CP, Dossetor JF, Penney MD. (1999) Nephrogenic diabetes insipidus due to a new mutation of the arginine vasopressin V2 receptor gene in a girl presenting with non-accidental injury. Ann Clin Biochem, 36 ( Pt 6): 779-82. [PMID:10586320]
7. Cheong HI, Park HW, Ha IS, Moon HN, Choi Y, Ko KW, Jun JK. (1997) Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus. Nephron, 75 (4): 431-7. [PMID:9127330]
8. Deen PM, Knoers NV. (1998) Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus. Am J Med Sci, 316 (5): 300-9. [PMID:9822112]
9. Dong Y, Sheng H, Chen X, Yin J, Su Q. (2006) Deletion of the V2 vasopressin receptor gene in two Chinese patients with nephrogenic diabetes insipidus. BMC Genet, 7: 53-53. [PMID:17101063]
10. Fujiwara TM, Bichet DG. (2005) Molecular biology of hereditary diabetes insipidus. J Am Soc Nephrol, 16 (10): 2836-46. [PMID:16093448]
11. Inaba S, Hatakeyama H, Taniguchi N, Miyamori I. (2001) The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus. J Clin Endocrinol Metab, 86 (1): 381-5. [PMID:11232028]
12. Kamperis K, Siggaard C, Herlin T, Nathan E, Hertz JM, Rittig S. (2000) A novel splicing mutation in the V2 vasopressin receptor. Pediatr Nephrol, 15 (1-2): 43-9. [PMID:11095010]
13. Knoers NV, van den Ouweland AM, Verdijk M, Monnens LA, van Oost BA. (1994) Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus. Kidney Int, 46 (1): 170-6. [PMID:7933835]
14. Kotnik P, Battelino T, Debeljak M, Podkrajsek KT, Waldhauser F, Frøkiaer J, Nielsen S, Krzisnik C. (2007) Correlation between AVPR2 mutations and urinary AQP2 excretion in patients with nephrogenic diabetes insipidus. J Pediatr Endocrinol Metab, 20: 483-489. [PMID:17550212]
15. Lolait SJ, O'Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ. (1992) Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature, 357: 336-339. [PMID:1534150]
16. Morin D, Ala Y, Sabatier N, Cotte N, Hendy G, Vargas R, Déchaux M, Antignac C, Hibert M, Bichet D, Barberis C. (1998) Functional study of two V2 vasopressin mutant receptors related to NDI. P322S and P322H. Adv Exp Med Biol, 449: 391-393. [PMID:10026830]
17. Moses AM, Sangani G, Miller JL. (1995) Proposed cause of marked vasopressin resistance in a female with an X-linked recessive V2 receptor abnormality. J Clin Endocrinol Metab, 80 (4): 1184-6. [PMID:7714087]
18. Oksche A, Möller A, Dickson J, Rosendahl W, Rascher W, Bichet DG, Rosenthal W. (1996) Two novel mutations in the aquaporin-2 and the vasopressin V2 receptor genes in patients with congenital nephrogenic diabetes insipidus. Hum Genet, 98 (5): 587-9. [PMID:8882880]
19. Oksche A, Schülein R, Rutz C, Liebenhoff U, Dickson J, Müller H, Birnbaumer M, Rosenthal W. (1996) Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function. Mol Pharmacol, 50 (4): 820-8. [PMID:8863826]
20. Pan Y, Metzenberg A, Das S, Jing B, Gitschier J. (1992) Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet, 2 (2): 103-6. [PMID:1303257]
21. Pasel K, Schulz A, Timmermann K, Linnemann K, Hoeltzenbein M, Jääskeläinen J, Grüters A, Filler G, Schöneberg T. (2000) Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families. J Clin Endocrinol Metab, 85 (4): 1703-10. [PMID:10770218]
22. Robben JH, Knoers NV, Deen PM. (2006) Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol, 291 (2): F257-70. [PMID:16825342]
23. Rocha JL, Friedman E, Boson W, Moreira A, Figueiredo B, Liberman B, de Lacerda L, Sandrini R, Graf H, Martins S et al.. (1999) Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus. Hum Mutat, 14 (3): 233-9. [PMID:10477431]
24. Sato K, Fukuno H, Taniguchi T, Sawada S, Fukui T, Kinoshita M. (1999) A novel mutation in the vasopressin V2 receptor gene in a woman with congenital nephrogenic diabetes insipidus. Intern Med, 38 (10): 808-12. [PMID:10526945]
25. Schülein R, Zühlke K, Krause G, Rosenthal W. (2001) Functional rescue of the nephrogenic diabetes insipidus-causing vasopressin V2 receptor mutants G185C and R202C by a second site suppressor mutation. J Biol Chem, 276 (11): 8384-92. [PMID:11116139]
26. Seibold A, Brabet P, Rosenthal W, Birnbaumer M. (1992) Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet, 51 (5): 1078-83. [PMID:1415251]
27. Szalai C, Triga D, Czinner A. (1998) C112R, W323S, N317K mutations in the vasopressin V2 receptor gene in patients with nephrogenic diabetes insipidus. Mutations in brief no. 165. Online. Hum Mutat, 12 (2): 137-8. [PMID:10694923]
28. Tajima T, Nakae J, Takekoshi Y, Takahashi Y, Yuri K, Nagashima T, Fujieda K. (1996) Three novel AVPR2 mutations in three Japanese families with X-linked nephrogenic diabetes insipidus. Pediatr Res, 39 (3): 522-6. [PMID:8929875]
29. Tsukaguchi H, Matsubara H, Aritaki S, Kimura T, Abe S, Inada M. (1993) Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus. Biochem Biophys Res Commun, 197 (2): 1000-10. [PMID:8267567]
30. Tsukaguchi H, Matsubara H, Inada M. (1995) Expression studies of two vasopressin V2 receptor gene mutations, R202C and 804insG, in nephrogenic diabetes insipidus. Kidney Int, 48 (2): 554-62. [PMID:7564126]
31. Wildin RS, Cogdell DE, Valadez V. (1998) AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus. Kidney Int, 54: 1909-1922. [PMID:9853256]
